Ikarian Capital »

Pelthos Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Pelthos Therapeutics shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 63k 28.00

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Pelthos Therapeutics

Murchinson
Vanguard Group
Ikarian Capital
Boothbay Fund Management
Diadema Partners
Geode Capital Management
Knott David M Jr
Steward Partners Investment Advisory
Tower Research Capital
UBS Group
Jpmorgan Chase & Co

View all funds holding Pelthos Therapeutics